The Growing Promise and Persistent Divide in Diabetes Telemonitoring

Diabetes telemonitoring technologies—continuous glucose monitors (CGMs), smart insulin pens, and mobile health apps—have transformed how patients manage their condition. These tools provide real-time data, reduce the burden of manual tracking, and enable timely interventions that improve glycemic control and quality of life. Yet, despite these advances, a significant digital health equity gap undermines the potential of telemonitoring: many of the individuals who stand to benefit most—those in rural areas, low-income households, ethnic minorities, older adults, and non-English speakers—are precisely the populations least likely to have reliable access, adequate training, or culturally appropriate support to use these technologies effectively.

This equity gap perpetuates a two-tiered system of diabetes care. Patients with resources and digital literacy achieve better outcomes, while vulnerable groups experience higher rates of complications, hospitalizations, and mortality. Addressing the underlying causes is not just a matter of social justice; it is a clinical imperative. Without targeted, systemic efforts, digital health innovations will only widen, rather than narrow, existing disparities in diabetes management.

Telemonitoring in diabetes goes beyond convenience; it represents a paradigm shift from episodic, clinic-based care to continuous, data-driven self-management. However, the benefits of this shift are unevenly distributed. A 2023 analysis in Health Affairs found that the highest CGM adoption rates occurred among non-Hispanic White patients with private insurance, while Black and Hispanic patients with public insurance were significantly less likely to use the technology, even after adjusting for clinical factors. This disparity translates into real-world consequences: missed opportunities for early detection of dangerous glucose excursions, increased emergency department visits, and higher long-term healthcare costs.

Understanding Digital Health Equity in Diabetes Telemonitoring

The World Health Organization defines digital health equity as the state in which everyone has a fair and just opportunity to attain their full health potential through digital technologies. In the context of diabetes telemonitoring, this means ensuring that all people with diabetes—regardless of income, geography, race, ethnicity, language, or age—can access, understand, and effectively use these tools to manage their condition.

According to the CDC’s National Diabetes Statistics Report, more than 38 million Americans have diabetes, and the prevalence is disproportionately high among American Indian/Alaska Native, Hispanic, and non-Hispanic Black adults. These same groups often face higher rates of poverty, lower broadband connectivity, and less access to specialty care—creating a perfect storm where the very populations with the greatest need for telemonitoring are the least likely to benefit from it.

Digital health equity is not solely about access to devices or internet connections. It also encompasses the ability to interpret data, integrate technology into daily routines, and trust that clinicians will use the data to improve care. These factors are shaped by social determinants such as housing stability, food insecurity, and health literacy. For example, a patient who struggles with consistent meal timing due to shift work or limited food choices may find CGM data confusing rather than empowering, especially if they lack guidance on pattern recognition. True equity requires addressing these multidimensional barriers in concert.

The Current Landscape of Telemonitoring for Diabetes

Telemonitoring encompasses a spectrum of technologies: from simple text-messaging reminders to sophisticated cloud-based platforms that aggregate CGM data, insulin pump settings, and activity logs for provider review. Studies show that consistent use of these tools can lower HbA1c levels, reduce hypoglycemic events, and increase patient engagement. However, most clinical trials have enrolled predominantly white, well-educated, insured participants with high digital literacy. Real-world uptake remains uneven. For example, Medicare’s expansion of CGM coverage in 2017 improved access for older adults, yet FCC Broadband Progress Reports indicate that nearly 20 million Americans still lack fixed broadband at threshold speeds needed for uploading CGM data, and the gap is especially acute on Tribal lands and in rural counties.

The telemonitoring ecosystem has grown rapidly, with new entrants offering smartphone-connected blood glucose meters, insulin dose calculators, and integrated platforms that combine multiple data streams. Yet many of these products were designed for early adopters who are comfortable with app-based interfaces and have reliable connectivity. A CGM that requires daily Bluetooth pairing and cloud synchronization to transfer data to a clinician may be unusable for a patient who shares a smartphone with a family member or lives in an area with intermittent cellular service. Similarly, smart insulin pens that log doses automatically assume the user has a compatible phone and is willing to carry both devices at all times. These assumptions exclude a substantial portion of the diabetes population.

Who Is Most Affected?

The digital health equity gap in diabetes telemonitoring disproportionately affects:

  • Rural populations — Limited broadband infrastructure and longer distances to endocrinology specialists reduce both access and clinical support for technology use. Rural residents with diabetes often rely on primary care providers who may lack telemonitoring expertise, and the nearest certified diabetes educator may be hours away.
  • Low-income individuals — High out-of-pocket costs for devices, monthly subscription fees, and smartphones create financial barriers. Even with insurance, co-pays can be prohibitive. Many patients must choose between buying a CGM sensor and paying for other necessities, leading to intermittent use that undermines clinical benefit.
  • Older adults — Age-related declines in vision, fine motor skills, and cognitive processing can complicate device use. Many CGMs rely on small touchscreens and complex mobile applications. Older adults also may be more resistant to learning new technology, especially if prior experiences with devices were negative or overwhelming.
  • Ethnic and linguistic minorities — Most diabetes apps and telemonitoring platforms are designed primarily in English, with limited translation of instructions or culturally tailored content. Even when translations exist, they may use formal language that does not match the colloquial dialects spoken by patients, or they may fail to address cultural beliefs about food and health.
  • People with limited digital literacy — A lack of familiarity with smartphones, data entry, and troubleshooting can lead to device abandonment and feelings of frustration or failure. This group includes individuals who have not grown up with digital tools and those with lower educational attainment who may struggle with numerical data interpretation.

Key Barriers to Equitable Telemonitoring Access

The obstacles are not merely technical—they are structural, financial, educational, and cultural. Addressing them requires a nuanced understanding of how each barrier operates in the context of diabetes self-management.

Infrastructure and Internet Access

Reliable high-speed internet is a prerequisite for many telemonitoring features, including real-time data sharing, cloud synchronization, and video consultations with care teams. According to the Pew Research Center, roughly 25% of U.S. adults with household incomes below $30,000 do not own a smartphone, and even among those who do, data plans may be insufficient for continuous use. Rural communities are particularly disadvantaged: the FCC reports that nearly 14.5 million rural Americans lack broadband access at speeds of 25/3 Mbps. Without a baseline expectation of connectivity, telemonitoring becomes unreliable, increasing the risk of missed alerts and incomplete data.

Infrastructure gaps are not uniform across the country. In some Tribal areas, fewer than 40% of households have any form of broadband, and cellular coverage is spotty. This means that a patient using a CGM that requires a smartphone to display glucose values may have no way to view their numbers when away from a Wi-Fi hotspot. In contrast, urban patients in well-connected neighborhoods can seamlessly upload data and receive remote feedback. This disparity creates a situation where telemonitoring works reliably only for those who already have the privilege of connectivity.

Device Availability and Affordability

Even when internet is available, the cost of approved glucose monitoring devices remains a barrier. CGMs typically cost $1,000—$2,000 per year out-of-pocket before insurance, and many low-income patients are uninsured or underinsured. Smartphone-based readers often require a specific device model or operating system version, further limiting options. Loaner programs and device subsidies exist in some health systems but are not widely available. Without access to the hardware itself, patients cannot begin the learning curve needed to become proficient.

The financial burden extends beyond the initial device purchase. CGM sensors must be replaced every 7—14 days, adding recurring costs that can strain limited budgets. Some patients resort to reusing sensors beyond their labeled duration, which can reduce accuracy and increase the risk of infection. Similarly, smart insulin pens require proprietary refills that may not be covered by all insurance plans. The overall cost of diabetes technology has been decreasing due to competition, but it remains out of reach for too many. Value-based pricing models, where payment is tied to outcomes rather than per-device charges, could help align incentives with equity.

Digital Literacy and Training Gaps

Possessing a device does not guarantee effective use. Digital literacy—the ability to find, evaluate, and communicate information through digital platforms—is a learned skill that varies widely. Older adults, individuals with lower educational attainment, and those with limited prior exposure to technology often require more time to master telemonitoring workflows. Many commercial diabetes apps assume high health literacy and numerical proficiency, with complex interfaces that display multiple graphs and trend lines. Without appropriate onboarding and ongoing support, patients can become overwhelmed and abandon the technology. A 2022 study published in the Journal of Diabetes Science and Technology found that nearly 30% of CGM users discontinued use within the first year, with lack of understanding cited as a primary reason.

Training must go beyond a one-time demo. Effective digital health literacy programs use a teach-back method, where patients demonstrate how to perform key tasks such as scanning a sensor, interpreting trend arrows, and responding to alerts. Hands-on practice with a coach who can answer questions and troubleshoot common problems is essential. For patients who are not comfortable with digital tools, simplified workflow guides with large font icons and step-by-step visual instructions can reduce cognitive load. Peer-led training groups, where experienced users mentor newcomers, have shown particular promise in building confidence and sustaining engagement.

Language, Culture, and Health Literacy

Cultural perceptions of diabetes, mistrust of medical technology, and language barriers all influence adoption. For example, some immigrant communities rely on traditional remedies or family members for advice rather than digital tools. Hispanic and Black patients are less likely to be offered CGM therapy by their providers, possibly due to implicit biases about adherence. Furthermore, most telemonitoring platforms are available only in English, with Spanish translations often done poorly or missing critical medical terminology. A 2021 study highlighted that non-English-speaking patients with diabetes had significantly lower rates of CGM use, even after controlling for insurance and income. Without culturally competent design and multilingual support, even the most advanced technology will be inaccessible to broad segments of the population.

Cultural competence extends to dietary guidance and meal logging features. For instance, a CGM app that includes only pre-programmed food items from a standard Western diet may frustrate patients who eat traditional foods like plantains, lentils, or chapati. Integrating culturally relevant food databases and allowing users to add custom entries with multilingual descriptions can improve adherence. Similarly, health coaching messages should be translated not just linguistically but also conceptually, using idioms and metaphors that resonate with each community. Building trust also requires transparent communication about data privacy, especially for populations that have historically experienced exploitation in medical research.

Primary care clinicians, who manage the majority of diabetes cases, may lack training in telemonitoring algorithms and data interpretation. Without confidence in their ability to act on device-generated information, they may be less likely to prescribe or reinforce use. Additionally, many electronic health records (EHRs) do not seamlessly integrate CGM data, forcing providers to log into separate portals or rely on patient-printed reports. This fragmentation increases clinician burden and reduces the likelihood that telemonitoring data will influence care decisions. Patients sense this lack of engagement and may feel their effort in using the device is wasted.

Provider education must address both technical skills and equity-conscious prescribing. Clinicians need to know not just how to interpret CGM trend lines, but also how to identify patients who would benefit most from telemonitoring and how to overcome common barriers. For example, a provider working in an underserved clinic might prescribe a CGM that works with a standalone reader rather than a smartphone, or connect patients with a digital navigator service. Medical schools and residency programs are beginning to incorporate digital health competencies, but progress is slow. Health systems can accelerate adoption by embedding telemonitoring champions within primary care teams and offering ongoing education through tele-ECHO sessions.

Strategies for Closing the Digital Health Equity Gap

Bridging the gap requires coordinated action across policy, technology, healthcare delivery, and community engagement. The following strategies represent a comprehensive, evidence-informed framework for making diabetes telemonitoring truly equitable.

Policy and Infrastructure Investments

Governments at federal and state levels must treat broadband access as a social determinant of health. The Affordable Connectivity Program, a Federal Communications Commission (FCC) initiative, provides discounts on internet service for low-income households; expanding such programs and linking them to diabetes care pathways can increase connectivity. Additionally, policymakers should incentivize device manufacturers to produce low-cost, basic models that do not require high-end smartphones. Medicare and Medicaid can drive equity by eliminating prior authorization requirements for CGMs among high-risk populations and by covering non-smartphone-based readers.

Regulatory changes can also reduce barriers. The FDA’s recent clearance of over-the-counter CGMs means that patients no longer need a prescription to purchase the device, potentially lowering access barriers for those without regular clinician visits. However, OTC CGMs still require a financial outlay and may not be covered by insurance. State-level initiatives, such as California’s Medi-Cal expansion of CGM coverage for all insulin-requiring patients, show that policy can directly impact equity. Federal legislators should consider mandating that all public insurance plans cover CGM for any patient with type 1 or type 2 diabetes on insulin therapy, without step therapy or prior authorization.

Healthcare System and Provider Training

Health systems should integrate digital health navigators into care teams—trained staff who assist patients with device setup, connectivity, and troubleshooting during clinic visits and via telehealth. These navigators can also provide one-on-one coaching to improve digital literacy. Provider education is equally critical: residency programs and continuing medical education (CME) courses should include modules on telemonitoring interpretation and equity-conscious prescribing. The American Diabetes Association’s Standards of Care now recommend that all patients with diabetes be evaluated for barriers to technology use at every visit.

Practical implementation of this recommendation requires embedding screening questions into the EHR workflow. A simple assessment could ask about internet access, smartphone ownership, language preference, and comfort level with technology. Based on responses, care teams can route patients to appropriate resources—such as a digital navigator, a social worker for connectivity subsidies, or a certified diabetes educator for training. Health systems that have piloted these models, such as the University of Mississippi Medical Center’s diabetes telemonitoring program for rural patients, have reported improved device retention and higher patient satisfaction.

Technology Design for Inclusivity

Developers must prioritize universal design principles. Simplified interfaces with large text, voice guidance, color-blind-friendly graphs, and offline data caching can help older adults and users with limited literacy. Multilingual support should go beyond translation to include culturally relevant graphics and examples. For example, a CGM app might include meal-logging templates for common ethnic foods rather than only Western meals. Real-time data synchronization with family caregivers (with patient consent) can create a support network. Companies like Dexcom and Abbott have begun offering stripped-down CGM receivers without phone dependency, but more options are needed.

Accessibility features should be designed from the ground up, not added as an afterthought. That means involving patients from diverse backgrounds in user testing and co-design processes. For instance, a CGM app that is designed with input from older adults might feature a simplified dashboard that shows only the current glucose value and a single trend arrow, with the option to tap for more detail. Voice commands for setting alarms or logging meals can assist those with motor impairments. Offline functionality is essential for patients in areas with intermittent connectivity; data can sync later when a stable connection is available. Open-source platforms like Tidepool demonstrate that interoperable, user-friendly tools are possible when the design focus is on inclusivity rather than vendor lock-in.

Community-Based Interventions

Community health workers (CHWs) and peer educators are trusted figures who can deliver culturally tailored telemonitoring training. Programs such as the Project ECHO model have demonstrated success in extending specialty diabetes care to rural areas via telementoring, integrating telemonitoring training into the curriculum. Similarly, libraries, faith-based organizations, and senior centers can host “tech clinics” where patients practice using their devices with support. Offering a dedicated device in a community setting—like a diabetes hub with on-site internet—can also lower the barrier for those without home connectivity.

Community-based models work because they leverage existing social networks and trust. A CHW who shares the same cultural background as the patient can explain telemonitoring benefits in terms that resonate, address specific fears (e.g., concerns about needles or data being shared with immigration authorities), and provide hands-on troubleshooting. In the Bronx, a peer-led CGM education program increased device initiation by 40% among Hispanic patients compared to standard care. Scaling such programs requires sustainable funding, which could come from value-based payment models that recognize the role of community health workers in improving outcomes.

The Role of Data and Interoperability

Even when patients successfully adopt telemonitoring, the data must travel to clinicians in a usable format. The lack of standardized APIs and EHR integration remains a significant roadblock. Health systems should adopt open standards such as HL7 FHIR to allow seamless data flow from devices to records. Additionally, population health dashboards that stratify patients by race, ethnicity, geography, and digital readiness can help identify equity gaps in real time. For instance, if a health system notices that only 15% of Spanish-speaking patients are active in their CGM program versus 60% of English-speaking patients, it can target resources accordingly.

Interoperability is not just a technical issue; it has clinical implications. When CGM data cannot be automatically pulled into the EHR, clinicians must either ignore the data or spend extra time manually entering it. This reduces the likelihood that data will be acted upon, which in turn discourages patient adherence. Some health systems have built custom interfaces that pull CGM data via vendor APIs and display it alongside other labs. For smaller clinics without IT resources, cloud-based platforms like Glooko or Diasend aggregate data from multiple devices and generate provider-friendly reports. However, these platforms often require subscription fees that may not be covered for underserved populations. Open-source alternatives, such as the Nightscout project, offer a free solution but require technical savvy to set up, limiting their reach.

Standardization could be accelerated by industry-wide adoption of the IEEE 11073 Personal Health Device communication standard, which defines how medical devices exchange data. The FDA has encouraged this through its guidance on interoperability, but voluntary adoption has been slow. Policymakers could mandate that devices covered by Medicare or Medicaid must support open, standard-based data exchange. Such a requirement would level the playing field, ensuring that new devices work with existing health IT systems rather than creating yet another proprietary silo.

Measuring Success and Ensuring Accountability

Closing the digital health equity gap requires metrics. Health systems should track not just telemonitoring enrollment rates but also device usage persistence (percentage of days with at least one CGM scan), HbA1c reductions stratified by demographics, and patient-reported satisfaction and confidence. Regulatory bodies like the Joint Commission could incorporate digital health equity criteria into accreditation standards. Payers, including Medicare and commercial insurers, could tie value-based payments to achievement of equitable telemonitoring outcomes. Without accountability, equity remains an afterthought.

Effective measurement requires granular data. A health system may report that its CGM program has 80% patient engagement overall, but that number could mask huge disparities: 95% engagement among White patients with internet access versus 45% among Black patients without. Disaggregating outcome data by race, ethnicity, income, geography, and language reveals where interventions are needed. The National Quality Forum (NQF) has endorsed several digital health equity measures, but adoption by health plans and hospitals is voluntary. Making these metrics part of mandatory quality reporting (e.g., through CMS’s Merit-based Incentive Payment System) would create a financial incentive for systems to address disparities.

Accountability also extends to device manufacturers and app developers. Companies that receive federal contracts should be required to demonstrate that their products meet accessibility standards and have been tested with diverse user groups. Consumer ratings and reviews on app stores often disproportionately reflect the experiences of tech-savvy, English-speaking users. Independent testing by organizations like the Digital Health Center of Excellence could provide transparency about how well devices perform across different populations, helping clinicians and patients make informed choices.

Case Studies in Equitable Telemonitoring

Highlighting successful programs that have closed the equity gap provides a roadmap for others. The University of Arkansas for Medical Sciences (UAMS) launched a telemonitoring program targeting rural patients with type 2 diabetes. Recognizing that many patients lacked smartphones, UAMS provided simple Bluetooth-enabled glucose meters that transmitted data via a cellular-connected hub. Patients did not need a smartphone or broadband. The program also assigned community health workers who visited patients at home to teach them how to use the device and interpret the results. Within one year, 70% of participants achieved a significant reduction in HbA1c, and the program was particularly effective for older adults and those with limited digital literacy.

Another example comes from the Los Angeles County Department of Health Services, which serves a largely low-income, immigrant population. They integrated CGM into primary care clinics and created a team of digital health navigators fluent in Spanish, Korean, and Armenian. Navigators called patients within 24 hours of device dispensing to provide setup support and scheduled follow-up calls weekly for the first month. They also provided paper-based logs for patients who preferred not to use the app. As a result, CGM persistence rates among non-English-speaking patients reached 80%, comparable to English-speaking patients. The program’s success relied on dedicated navigator funding, which was covered by county funds and a state innovation grant.

These case studies underscore the importance of tailoring the delivery model to the population. In rural Arkansas, the key was eliminating the smartphone requirement; in urban Los Angeles, the key was multilingual, high-touch support. Both programs invested in human capital and intentionally designed for the most vulnerable users rather than defaulting to the “average” patient. These approaches are scalable if health systems reallocate resources toward equity-focused telemonitoring.

Future Directions and Emerging Technologies

The field of diabetes telemonitoring is evolving rapidly, with new sensors, artificial intelligence, and digital therapeutics on the horizon. Artificial intelligence algorithms can now predict hypoglycemic events up to two hours in advance, and closed-loop systems that automatically adjust insulin delivery are becoming more widespread. Without an equity lens, these innovations risk deepening the divide. For example, AI models trained primarily on data from White patients may be less accurate for other groups, leading to false alarms or missed detection. Ensuring diverse representation in training datasets is essential for fairness.

Digital therapeutics—prescription software that delivers behavioral interventions—are also entering the market. These products must be designed with the same inclusive principles as hardware devices. They should work offline, be translated into multiple languages, and incorporate culturally relevant content. Additionally, as telemonitoring expands, the role of health coaches and virtual care teams will grow. Ensuring that these teams reflect the diversity of the patient population can improve trust and communication.

One promising development is the use of community-based data hubs. Rather than requiring each patient to have their own internet connection, a hub could aggregate data from multiple patients in a rural clinic or senior center and transmit it securely to specialists. This approach reduces the need for individual broadband subscriptions and can be more cost-effective for health systems. Pilot programs using satellite internet and mesh networks are underway in Alaska and the Navajo Nation. If successful, they could serve as models for other remote areas.

Conclusion: A Call for Concerted Action

Diabetes telemonitoring holds enormous promise to improve outcomes, reduce costs, and empower patients. But that promise is hollow if it only reaches those who already have advantages. The digital health equity gap in diabetes telemonitoring is not inevitable; it is the result of decades of underinvestment in infrastructure, design bias, and clinical inertia. By prioritizing policy reform, inclusive technology, provider education, and community partnerships, we can ensure that every person with diabetes—regardless of zip code, income, language, or literacy—benefits from the tools that can save their vision, kidneys, and lives. The time to act is now, while the technology landscape is still malleable and before another generation of patients is left behind.

The path forward requires uncomfortable conversations about systemic bias, resource allocation, and the true cost of inequity. It demands that clinicians, developers, payers, and policymakers see digital health equity not as a niche concern but as a core component of quality diabetes care. Every missed opportunity to close the gap is a missed opportunity to prevent a stroke, a foot amputation, or a kidney failure. The data are clear: telemonitoring works when it is accessible, usable, and supported. Our collective responsibility is to make that a reality for all.